Search

everythinglearnresearchcommunity

for

Search:↓

The PTGER2 gene is highly active in Cashmere goat skin and its activity changes with the hair growth cycle.

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Blocking Prostaglandin D₂ may help treat hair loss.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Key genes and pathways, including Wnt, NF-Kappa, and JAK-STAT, are crucial for starting Pashmina fiber growth in goats.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

Wnt3a activates certain genes in hair follicle cells, including a newly discovered one, EP2, which may affect hair growth.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Prostaglandin D₂ might be targeted for new male pattern baldness treatments.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Gypenosides from Gynostemma pentaphyllum were found to have anti-aging effects, increasing skin collagen and reducing wrinkles.

PGD2 stops hair growth and is higher in bald men with AGA.

Multiple treatments work best for hair loss.

New treatments for hair loss may target specific pathways and generate new hair follicles.

New methods efficiently isolate dermal papilla cells from hair follicles, preserving their characteristics better than traditional methods.

SFRP2 and PTGDS may be key factors in female hair loss.

Skin and hair can regenerate after injury due to changes in gene activity, with potential links to how cancer spreads. Future research should focus on how new hair follicles form and the processes that trigger their creation.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

Fat cells in the skin help start healing and form important repair cells after injury.

Minoxidil helps hair growth by activating the β-catenin pathway.